Because increased glucose and insulin concentrations were the primary indicators for insulin resistance and type 2 diabetes (4, 39), beta-glucan markedly improved insulin resistance (Table 3) by decreasing fasting serum glucose and insulin levels both in low-dose and high-dose control groups compared with that of MC group. This evidence concerns the gene INS and Insulin resistance.